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a b s t r a c t
This paper presents Vesta, a digital health platform composed of a smart home in a box for data
collection and a machine learning based analytic system for deriving health indicators using activity
recognition, sleep analysis and indoor localization. This system has been deployed in the homes
of 40 patients undergoing a heart valve intervention in the United Kingdom (UK) as part of the
EurValve project, measuring patients health and well-being before and after their operation. In this
work a cohort of 20 patients are analyzed, and 2 patients are analyzed in detail as example case
studies. A quantitative evaluation of the platform is provided using patient collected data, as well as
a comparison using standardized Patient Reported Outcome Measures (PROMs) which are commonly
used in hospitals, and a custom survey. It is shown how the ubiquitous in-home Vesta platform can
increase clinical confidence in self-reported patient feedback. Demonstrating its suitability for digital
health studies, Vesta provides deeper insight into the health, well-being and recovery of patients within
their home.
© 2020 Published by Elsevier B.V.1. Introduction
A significant challenge facing society today is how to better
tilize technology to improve lives. One such method is the
se of sensing technologies and the Internet of Things (IoT) to
onitor health and well-being. Ambient Assisted Living (AAL) is
ast and recently projects such as SPHERE [1] have been devel-
ping solutions for healthcare in the smart home environment.
his typically involves the deployment of a myriad of sensors
n the home, ranging from video cameras and wearable devices,
o presence and energy sensors. Other systems include sensors
hat also monitor computer activity, medication consumption and
ehicle driving [2]. The benefit of these systems to healthcare
re clear [3,4]. However, with such systems, installation and cost
s non-trivial; scaling such systems to large numbers of people
uickly and efficiently remains a challenge [5].
Vesta was developed as part of the EurValve project [6]. One
f the objectives of the project is to measure the health, quality of
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0167-739X/© 2020 Published by Elsevier B.V.life, and recovery of heart valve intervention patients over differ-
ent stages of their care. The ideal system would be self-deployable
and cost-effective, yet precise in its measurements. Therefore, a
smart home in a box was developed with these constraints in
mind. The smart home in a box is an easily installable pervasive
home health monitoring system that collects sensor data from
the environment, but at a fraction of the deployment, sensing and
maintenance costs of comparable systems. Ease of installation of
the smart home in a box is vitally important for many reasons
in the EurValve project. First, during a clinical consultation the
smart home in a box will be given to the patient. The patient will
then be expected to bring the smart home in a box home and
set it up without any further help from their doctor. Secondly,
the demographic of the patients is likely one of poor health and
non-technical. Once deployed, it is intended that the system will
be maintenance free, which is helped by having fewer sensors,
lessening the potential for technical problems and failures.
The primary sensor in the smart home in a box is a wrist-worn
wearable that contains a tri-axial accelerometer, that connects to
four gateways that are placed around the home. Accelerometers
measure acceleration along the x, y, and z directions and thus
provide insight into the activities of the person wearing the
device. Each gateway records Received Signal Strength Indicator
(RSSI) values when they receive data from the wearable. This can
be used as an estimation of the location of the wearable, and
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router is also supplied which securely transmits the sensor data
to a remote server for analysis. As the smart home in a box is
constantly sensing when the patient is at home, a large amount of
data will collected. In order for a healthcare professional to make
use of this data an analytic platform was developed that uses
machine learning to help measure the well-being of the patient.
This is achieved via recognizing activities in the data, tracking the
patient continuously within their home, as well as measuring the
quantity and quality of their sleep. The platform supports many
visualizations to help understand the data via health indicators.
As part of the project, 40 patients who are undergoing a heart
valve intervention were recruited. For each recruited patient,
their levels of activity are measured using this platform in their
home environment. In order to gain more quantitative insight
into the health of patients undergoing heart valve interventions,
this is measured over three stages of their care. The first stage
occurs for two weeks pre-operation, the second stage for two
weeks soon after the operation, and the final stage 12 to 16 weeks
after the operation. Each of the three stages collect around two
weeks of data. Throughout this text the stages will be referred
to as pre-operation, post-operation and the follow-up period.
Thus in total, the aim is to collect six weeks of in-home data for
each patient. During these stages the patients are instructed to
use the wrist-based wearable as much as possible, except when
bathing, when it is suggested they can recharge the device. This
results in a huge amount of sensor data collected for each patient
over key points of their care. Ethical approval for the study was
granted by NHS Research Ethics Committee (REC) under reference
17/LO/0283.
The main contributions of this work are as follows:
• An end-to-end platform is proposed for digital health stud-
ies which consists of a lower cost, easy to use smart home
in a box and a data analytics system for the analysis and
visualization of health indicators derived from the data. The
platform is designed such that patients are able to deploy
the system within 30 min using the simple deployment
procedure and immediately commence the data collection.
• The platform is deployed in the homes of patients, monitor-
ing them before and after a heart valve intervention, demon-
strating the ability of Vesta to infer relevant health and
well-being indicators, and visualize them in a suitable way.
This uncovers insight into the recovery of patients that is
otherwise not possible using current common clinical mea-
sures, such as Patient Reported Outcome Measure (PROM)
surveys and routine tests carried out within hospitals, such
as the 6 Minute Walk Test.
• An analysis of twenty patients of the intervention is pre-
sented, analyzing health indicator trends throughout their
intervention, as well as two in-depth patient case studies.
The larger cohort analysis demonstrates each patients health
indicator trend over each stage of the intervention, exem-
plifying health indicators such as duration outside, indoor
mobility and sleep quality. Further, the individual case stud-
ies exemplify two different outcomes for patients and how
Vesta captures this.
• The results are externally validated with both standardized
surveys, as well as a custom survey, that were completed by
the patients. While these surveys are limited by their sub-
jectiveness or non-pervasiveness, they serve as a clinically
validated method for assessing outcomes. By using these
as the ground truth of patient outcomes, the performance
of Vesta is measured, demonstrating the potential of using
a pervasive home health monitoring platform to augment
current clinical measures.2. Related work
There is much research in the literature on IoT sensing tech-
nologies in the home [8], activity recognition and health moni-
toring using wearables [9,10], and indoor localization using RSSI
[11], as well as combinations of both [12,13]. Such research is
often known as ‘Ambient Intelligence’ [14], ‘Ambient Assisted
Living’ (AAL) [15] as it concerns building smart environments,
typically in the home, that are able to assist people in their daily
lives.
An important application of AAL is for healthcare purposes,
evidenced by the development of intelligent smart home envi-
ronments for conditions ranging from Alzheimer’s disease [16],
dementia [17], diabetes [18], and surgery recovery [19]. Zheng
et al. [20] provide a broad overview of different types of sensing
and wearable technologies for health informatics, and
Amiribesheli et al. [21] provide a review of smart homes in
healthcare. Indeed there have been suggestions of using such
systems for predictive monitoring [22]. However they are typ-
ically studied as isolated problems and not often within the
larger context of a single smart home data collection and analytic
platform for digital health.
Further, there are relatively few platforms available for digital
health in the context of a smart home in a box, or more generally
in the realm of lower cost and easily deployed systems for health
analytics in the home environment. Abdulrazak and Hela [23]
introduced the concept of a smart home in a box in their work
which proposes a low-expertise method of integrating various
in home devices. Beckmann et al. [24] proposed a smart home
in a box where participants receive a system by mail, but the
intent was to measure ease of use, and the focus was not on the
collection of health related data. Further, neither of these systems
cover the analytical aspect.
The most similar systems are those from the Center for Ad-
vanced Studies in Adaptive Systems (CASAS) [8,25]. While similar
in principle, it contains many more sensors than the presented
system and takes longer to install. The CASAS system deployed
in [8] consisted of between 8 and 18 sensors, including motion,
temperature and door sensors and a relay and server. They con-
cluded that this system was intuitive for participants to install.
This provides a degree of validation of the ease of installation
of our system which consists of much fewer sensors. In terms
of cost, our system consists of a wrist-worn accelerometer, four
Raspberry Pis (as gateways) and one 4G router, thus we ex-
pect to be lower cost than the much more numerous sensors,
relay and server of the CASAS system. The Vesta smart home
in a box, including the calibration phase, takes around 20 to
30 min to set up and is specifically tailored for studies of digital
health with feedback and input from clinicians, and refinement
based on patient feedback. Nonetheless, without the low-cost
and easily deployed constraints, there are a number of projects
working towards deploying IoT sensing technologies into the
home environment, and in particular for digital health.
Arguably the most notable system is the SPHERE project [1]
which, aims to collect up to one year of data from 100 dif-
ferent homes, and consists of a multitude of different sensors
capturing many modalities within a home environment. In fact,
this system has been deployed in a healthcare study, as part of
the HEmiSPHERE project, on patients undergoing hip and knee
replacements [26,27]. The HEmiSPHERE system protocol paper
states that the system deployment target is 30 homes, 10 less
than the number of homes from which we collected data. How-
ever, a key difference is that the HEmiSPHERE system contains
many sensors, thus increasing the cost, and requires technicians
to install the system, thus affecting the ease of deployment.
There are a myriad of social and ethical issues to be considered
when deploying AAL technology in the homes of patients, such as














































gnformed consent, privacy, security, safety and trust [28]. When
sed in research or clinical studies, such systems can collect
ensitive information that relates to activities of daily living (such
s sleeping patterns, movement patterns, time spent outside the
ome). Therefore, ongoing informed consent of such systems is
equired, as well as trust in the system and researchers to keep
heir data safe, secure and anonymous during transmission and
torage [21,29].
Researchers have also studied the effect of information tech-
ology systems on patient health and behaviour change, indi-
ating that they usually have a positive impact on patient be-
aviour [30]. While positive, it is nonetheless worth acknowledg-
ng that the presence of a home monitoring technology in medical
tudies may effect change in the patients behaviour [31].
Cost-effectiveness is also a concern as smart home technology
as an inherent financial cost and can therefore affect health
quity [28], with systems ranging from those requiring profes-
ional installation and many sensors [1] to what we propose, a
mart home in a box which contains significantly fewer sensors, is
elf-installable and more cost-effective than similar smart home
ystems.
. Platform overview
First, an overview of the entire Vesta platform is provided,
rom the collection of sensor data using the smart home in a box
o deriving health indicators and visualization. Fig. 1 depicts the
eneral structure of the platform, from the hardware kit itself to
he analytic system which processes the collected data.
.1. The smart home in a box
Each smart home in a box primarily consists of one wearable,
our gateways and a router. The complete description of the kit
s detailed by Pope et al. [6], but in essence the design of the
urValve smart home in a box was to be an energy efficient and
ower cost smart home in a box, built with ease of use in mind.
The wearable [32] consists of a processor/radio, accelerometer,
xternal flash, and a battery. The wearable uses a System on
Chip (SoC) CC2650 processor with an integrated Bluetooth
ow Energy (BLE) radio. The wearable runs bespoke software
eveloped using an embedded real-time operating system. The
earable takes 5 accelerometer samples over a 200 millisecond
eriod (i.e., 1 sample every 40 ms) and transmits the samples
n the payload of a BLE advertisement packet. Thus, 5 packets,
ach of which are 20 bytes containing 5 tri-axial samples and
sequence number, are transmitted per second. To conserve
nergy, the SoC enters a low power mode between accelerometer
ampling and only enters full power mode when transmitting.
he transmitted packets contain a monotonically increasing se-
uence number (the sequence number starts from zero each
ime the wearable boots) and the estimated battery level. The
earable uses the ADXL362 accelerometer. It is configured to take
5 samples per second, with each 8-bit sample representing ± 4
. This is done for each x, y and z axis. The wearable has been
shown to last for approximately 21 days without recharge [6],
which is notably longer than each 2 week stage of the EurValve
study.
Raspberry Pis that come equipped with a compatible BLE
radio are used as static gateways. Software was developed to
receive the raw BLE packets from the radio and record the RSSI.
The packet is parsed and the sequence number, accelerometer
samples, RSSI, and battery level are saved to a file along with a
timestamp recorded when the packet was received. The gateways
are configured to use common Network Time Protocol (NTP)
servers to obtain their time and thus keep packets in sync. ThisTable 1
An example of the format for accelerometer data.
Timestamp x y z
2018-01-24 19:05:52.994200 −0.1875 −0.96875 0.0625
2018-01-24 19:05:53.034200 −0.1875 −0.9375 0.15625
2018-01-24 19:05:53.073200 −0.03125 −0.8125 0.125
timestamp, along with the packet sequence number, allows the
data from each of the gateways to be aligned.
The router acts as a WiFi access point for the gateways and
provides a mobile network link controlled by a compatible na-
tional carrier SIM card, and facilitates the secure transmission of
the data from the patients’ home to a remote server.
3.2. Data
The primary sources of data are the acceleration information
coming from the wearable device (for activity recognition and
sleep quality), and the RSSI values collected from each of the gate-
ways (for indoor localization). See Tables 1 and 2 for examples of
each, respectively.
Generally these types of datasets are heterogeneous and com-
plex in nature. They consist of different data formats and repre-
sentations due to the variations in the way wearables record data,
as well as the data they record. To represent the accelerometer
data, later used for activity recognition and sleep analysis, the
lowest common representation is used, that is, a timestamp t ,
followed by the x, y and z values for this time epoch. For localiza-
tion, the format expects a timestamp t followed by a RSSI value
for each gateway. If the dataset is for training, then the label is
also permitted. Otherwise, it is expected that data collected from
other devices can be converted to this format, thereby providing
a common, simple, understandable representation. Thus, to use
data from different devices with Vesta, one merely needs to
convert the specific dataset to this standard representation.
In environments where there are multiple gateways, such as
the smart home in a box within this platform, the monotonic
sequence number of each packet sent from the wearable and
received at the gateway is used as an identifier for merging
packets from the multiple gateways. It should be noted that as
the wearable does not currently maintain time of its own, and
time may drift on the gateways where the packets are recorded.
This, combined with the fact that the sequence number may
reset to zero in different scenarios, can lead to cases where
the sequence number may not be unique, where each gateway
records a packet with the same sequence number at different
timestamps t . Thus, a constraint is imposed on merging sequence
numbers; only timestamp and sequence number pairs where the
sequence number is identical and the difference in timestamps
is not greater than 30 min are merged. In such cases the earlier
timestamp is chosen as the authoritative one. Missing RSSI values
for a given second indicates that no gateway is in range, and thus
a missing value of −120 dB is instead used, which is a value not
possible if in range of a gateway.
Periods of time where the patient is not wearing the wearable
are excluded by measuring the standard deviation in acceleration
over smoothed 30 min blocks of time. If the standard deviation
of any two axis is less than 1.8mg, that block of time is excluded
from analysis. Further, days in which the patient spent less than
10 h in their home were excluded.
3.3. Data analytics
This section will describe how data science underpins the
overall platform.




























eFig. 1. An overview of Vesta, a platform which primarily consists of a smart home in a box for data collection and an analytic component for automated machine
learning, analysis and visualization of health indicators.Table 2
An example of the required format for RSSI data.
Timestamp 1 2 3 4
2018-01-24 19:05:53 −78.0 −96.0 −86.4 −59.6
2018-01-24 19:05:54 −87.5 −120.0 −81.67 −63.75
2018-01-24 19:05:55 −83.0 −89.5 −77.75 −59.75
3.3.1. Algorithms
The main learning tasks involve activity recognition and in-
oor localization. It is important that any digital health platform,
hat aims to be as flexible as possible, must provide the possibility
or selection and configuration of different algorithms due to the
o free lunch theorem [33]. For example, Twomey et al. [34]
llustrate the vast array of features and algorithms typically used
n the task of activity recognition. In Section 4 the specific choice
f algorithms and features is discussed in detail.
.3.2. Health indicators
There is no standard set of indicators that uniquely measure
he health or well-being of a patient. While the platform is
valuated in the context of one specific study, with one specific
linical population, it is envisaged that it could be used for a range
f other tasks within the wider area of digital health. Thus the
hoice of health indicators calculated from the data should not
e fixed, but easily extendable. For example, with access to the
earable accelerometer and localization information, it would
e possible to measure the patients speed at which the climb
tairs. Health indicators can further be extended with the use of
dditional sensors, such as a video-based sensor that can measure
hanges in patients sit-to-stand movement after hip or knee
eplacement [35]. For the purposes of this study, the clinically
nteresting health indicators measured in the setting of patients
ndergoing a heart valve intervention, which were chosen after
onsultation with clinicians, are:
• The duration spent walking over different stages of their
care.
• The duration spent in various rooms and the number of
transfers between rooms.
• The duration spent outside of the home.
• The quality and quantity of sleep.
ach health indicator will be analyzed over the three stages of
ntervention.
.3.3. Visualization
A key aspect of Vesta is the ability to display the knowledge
xtracted from the data in a useful way for healthcare practition-
rs. Due to the large amount of sensor data that is continuouslycollected by each smart home in a box, in each home, this is
vitally important. Effective visualization should give an overview
of key behavioural patterns at various levels of granularity. The
reader is referred to the evaluation in Section 4.4 for visualization
examples from patient data.
4. Evaluation
As discussed, the motivation behind the development of this
platform is the EurValve project. Recall that this involves per-
vasively monitoring patients who are undergoing a heart valve
intervention pre-operation, post-operation and a 12 to 16 weeks
follow-up period. However, due to the lack of ground truth, which
would be invasive and time consuming to collect, the primary
source of validation are subjective methods such as patient re-
ported measures of their own health and well-being. They take
the form of PROMs and are carried out once before the operation,
and once after. However this is a strong justification for the use
of Vesta, which provides longitudinal pervasive and quantitative
measures of health and well-being over significant periods of
time. Nonetheless, for external validation of the performance of
the platform, both PROMs and the clinician’s input are used.
While this platform will be evaluated retrospectively, future work
will study how such a system could be used in a decision support
system.
4.1. Machine learning models and algorithms
As the focus of this work is not the development of novel
machine learning algorithms, sensible methods are chosen that
are known to perform well from the literature.
4.1.1. Activity recognition
Random Forests have been shown to be effective at the task
of recognizing activities from accelerometer data [36], as well
as generally being robust and efficient. Hyper-parameters for
the Random Forest are found by a randomized search of the
parameter space and 10 fold cross validation. As training data,
the SPHERE challenge dataset [37] is used. This is a public dataset
consisting of numerous sensor modalities, including accelerome-
ter data using a similar wearable, collected from 10 participants
who were following a script taking roughly 20 to 30 min to
complete. Most participants completed the script twice. While
the SPHERE challenge dataset has many ambulation and transi-
tion activities labelled, three specific activities walking, lying and
sitting are selected for training the model. Further, as part of
the EurValve project, patients are asked to perform a calibration
procedure each time they deploy the system in their home [11].
During this calibration process patients perform 3 pre-defined





























































tctivities, walking, sitting and lying. Thus, the patient-calibrated
ata can be integrated into the training data for activity recog-
ition. A variety of features which are typically found in the
iterature [34,38,39] are used, and are extracted over 3 s win-
ows, with 66% overlap; the mean, variation, standard deviation,
in, max, median, 25 and 75 percent quartiles, the interquartile,
kewness and kurtosis, number of zero crossings, and the spectral
nergy and entropy of each axis. For predictions the same process
s applied to the patient accelerometer data.
.1.2. Localization
Learning a model for indoor localization, particularly in the
ontext of smart home in a box environments, is challenging. This
s due to each model being specific to one home, and thus the
haring of models, unlike for activity recognition, is not possible.
further challenge is introduced by the fact we cannot collect
ccurate environmental information of patients homes and thus
annot be taken into consideration. However, previous work has
tudied the effect of the environment [13] and sensor place-
ent [40] for RSSI based localization when this information was
vailable. Further, these were evaluated in the context of high
esolution localization within the room, but required significant
raining data for each location within the room. Thus, for this,
e trade within-room localization to room-level localization in
rder to reduce the amount of training data to be collected and
nnotated. We refer the interested reader to the work of Byrne
t al. [13] and Kozłowski et al. [40] to understand the capabili-
ies of, and requirements for, more detailed within-room indoor
ocalization using BLE RSSI.
To perform localization, the raw RSSI data is smoothed with
rolling 30 s window and the following features are calculated,
rom each of the four gateways over a 10 s window, with 50%
verlap; the mean, variation, standard deviation, min, max, me-
ian, 25 and 75 percent quartiles, the interquartile, skewness and
urtosis. The same process is applied to the patient RSSI data and
Random Forest, with 250 estimators, is used for predictions.
andom Forests, with this calibration process for indoor localiza-
ion, has previously been shown to be effective in this setting and
ystem [11,41] when compared with a number of other potential
ethods.
The calibration process generates training data that is typically
iewed as a vector of RSSI fingerprints corresponding to each
ateway, which can be used for location prediction. An example
f what a calibration looks like from the RSSI values can be
een in Fig. 2. The calibration procedure for localization has been
reviously described and tested by McConville et al. [11] but can
e briefly stated as follows. The patient is instructed to, for two
inutes in each room, sit in the living room, walk in the kitchen,
ie down in the bedroom, and carry out a typical activity in the
oom of the fourth custom gateway.
Due to the variability, multipath and interference effects as-
ociated with RSSI [11,42], in addition to the extremely limited
mount of training data, the predictions are smoothed over by
nly predicting a room change when at least 2 s of walking
ctivity is detected within the current localization time window.
n addition, rooms in which the patient spent less than 60 s are
onsidered as transitional rooms, and thus removed. Further, due
o the large window of time in which the patient is monitored,
p to around four months from the first to the last deployment,
here is ample opportunity for the environment to vary. This is
articularly relevant as, due to human factors, a successful cali-
ration is not always carried out at each deployment. To account
or environmental variability, the calibration data is augmented
o simulate changing environmental conditions with an increase
n dropped packets. Given the RSSI calibration data, up to 50% of
he RSSI fingerprints with all gateways in range are duplicatedfor the simulation. For each of these samples, a random gateway
is selected, and it is assigned the out of range value (−120 dB)
before being added back to the training set as an additional
sample.
4.1.3. Sleep
Sleep is considered to be vitally important to health and well-
being [43]. From a wrist-worn accelerometer it has been shown
possible to determine if the wearer is sleeping [44,45]. The algo-
rithm in Vesta builds on these methods, with a few modifications.
In their work, van Hees et al. [44] use a 5 min interval upon
which the change in arm angle is calculated to determine if a
wearer is sleeping. In their most recent work [45] they operate
on smoothed 5 s intervals, automatically determine the threshold
of permitted change by the 10th percentile, multiplied by 15,
for each day. They identify the longest daily block consisting of
values under the threshold, merging time gaps less than 60 min
to discover the Sleep Period Time-window (SPT).
Instead, the sleep analysis of Vesta permits gaps of up to
120 min to be merged as part of the SPT, based on experimental
validation from a subset of selected patients in the EurValve
cohort. Further, Vesta also records sleep periods outside of the
SPT to capture possible daytime somnolence. In addition, to im-
prove robustness, location information is integrated into the sleep
detection algorithm. For example, if the wearer has changed room
within the 30 min window, then they cannot have been sleeping.
This extra source of information can help distinguish natural
movements during sleep (e.g., rolling over) from actual non-
sleeping movements (e.g., going to the bathroom). Sleep analysis
within Vesta further permits the merging of sleep episodes, which
are distinct periods of sleep separated by non-sleep periods, if
they are between midnight and 7am, and the sleep onset time
is less than 120 min from the previous time of awakening. Sleep
episodes are still merged, regardless of room transitions, if room
transitions occurred between midnight and 7 A.M.
A number of health indicators are derived from the sleep
analysis component of the platform.
• The ‘main sleep’ is calculated as the largest period of sleep
in a 24 h day, the SPT.
• Additional periods of sleep are calculated, i.e., sleep
episodes, throughout the day. These can then be used to
report the total number of daily sleeping episodes as well
as the total duration spent sleeping per day.
• A sleep quality index is derived which is the length of the
daily SPT, divided by the number of minutes spent awake
during this period. This is further normalized over the dis-
tance duration of the SPT in hours, from 8 h. This causes a
sleep duration outside the range of 7 to 9 h to be penalized.
4.2. Quantitative evaluation
To gain confidence in the analysis, a means of validating the
models built using the patient training data is required. As each
patient was asked when deploying the smart home in a box to
carry out a short calibration procedure which generates activity
and localization labels, this can be used as a form of quantitative
evaluation.
4.2.1. Activity recognition
The evaluation of the performance of the activity recogni-
tion model is challenging due the small amount of labelled data
available. The labels are gathered from the calibration process,
typically carried out by patients in their own home, unsuper-
vised, and with minimal instruction. Therefore, one relies on the
patients precisely carrying out the calibration, which involves












HFig. 2. An example of the RSSI values for each room, automatically segmented from the calibration.Table 3
A selection of relevant questions from the PROM for patient A. In MLHFQ 0 corresponds to ‘no’, 1 ‘very little’ and 5 ‘very much’. In
WHOQOL 1 corresponds to ‘very little’, 2 ‘poor’, 3 ‘neither poor nor good’, 4 ‘good’ and 5 ‘very good’. The patient reports that in
almost all aspects they have improved, which corresponds to the analysis. One exception is sleep, with the patient reporting some
difficultly sleeping at night (MLHFQ) and falling to sleep quickly (SEQ). This corresponds to the small decrease in sleep quality seen
in Fig. 4.
Did your heart valve disease prevent you from living as you wanted in the last 4 weeks by Pre-op Follow-up
... making you sit or lie down to rest during the day (MLHFQ) 2 0
... making your walking about or climbing stairs difficult (MLHFQ) 3 0
... making your working around the house or yard difficult (MLHFQ) 3 0
... making your going places away from home difficult (MLHFQ) 2 0
... making your sleeping well at night difficult (MLHFQ) 0 2
How well are you able to get around? (WHOQOL) 3 5
How satisfied are you with your ability to perform daily living activities? (WHOQOL) 2 5
How satisfied are you with your sleep? (WHOQOL) 4 4
Estimated hours per week you walk (SEQ) 1+ 1+
Once you go to bed do you fall asleep quickly? (SEQ) Most/Every day Sometimes
Do you wake up fairly fully during the night? (SEQ) Never/Rarely Never/Rarely
Do you get up during the night? (SEQ) Sometimes Sometimes
Do you feel well-rested after sleep? (SEQ) Sometimes Most/Every day
6MWT distance (m) (6MWT) 398 478undertaking a specific activity for a set period of time. If the
patient performs the activity for less time than instructed, or
does not carry a single activity for the full duration, e.g., when
instructed to be walking and periodically standing, noisy labels
are obtained. The calibration is further limited in that patients
may sit, lie and walk in a very specific way; e.g., if they lie in a
single position in their bed during the calibration, this may not be
representative of how they lie over the course of a night sleeping;
consider lying on your side versus back versus front. Further,
accelerometers capture each person’s individual signature for
various activities [46] which, due to the limited labelled data
collected for each participant, means that combining the calibra-
tions of many patients is not the equivalent to the same quantity
of labelled data for a single person. Nonetheless, it is possible
to combine activity calibrations for numerous participants, along
with the SPHERE challenge dataset, or any other similar wrist-
based accelerometer data. The model built on the combination of
patient specific activities and the SPHERE challenge activities will
be evaluated using k-cross fold validation, where k = 10.
.2.2. Localization
Building a radio map of the home via the collection of RSSI
ingerprints during the calibration is essential for the indoor
ocalization. As the radio map is specific to each home, there
s a limited amount of labelled data. However, as each patient
as asked to carry out the calibration for each stage, ideally
alibrations were carried out on up to three occasions within
he home of the patient. To ascertain a level of confidence in
heir effectiveness k-cross fold validation of each of the patients
ocalization calibrations is used, where k = 10. It should be
oted that the calibration training data is relatively controlled
ompared to the normal behaviour of patients in their home.
owever, in the predictive phase, a constraint requiring walkingto be detected during room transfers is used in conjunction with
the RSSI features, which should decrease false transitions. Readers
are referred to previous work [11] which demonstrate that the
same calibration procedure with Random Forests achieves high
performance in an unscripted free-living localization task in a
residential house.
4.3. PROM evaluation
While the calibrations provide some ground truth data, as the
system is deployed in the homes of patients over long periods
of time, this ground truth data does not provide a satisfactory
performance evaluation of the long term effectiveness of the plat-
form. However, to supplement this, patients completed a number
of surveys at the beginning of the pre-operation and follow-up
stages. Namely, they are the Minnesota Living with Heart Failure
Questionnaire (MLHFQ), which has been validated in heart valve
disease [47], the World Health Organization Quality of Life-BREF
(WHOQOL) [48], the 6 Minute Walk Test (6MWT) [49,50] and
the SPHERE EurValve Questionnaire (SEQ). Examples of relevant
question and answers can be found in Tables 3 and 4.
4.3.1. PROM comparison
PROMs are standardized medical surveys used by hospitals
which measure a patient’s self-reported health and quality of life
at a given point in time. They are typically administered before
and after a procedure, and thus align with the deployment of the
smart home in a box.
The WHOQOL is a standardized form which aims to assess
how the patient feels about their own quality of life and health.
Using these survey responses to the following questions may be
useful for validating the proposed platform; ‘How well are you
able to get around?’, ‘How satisfied are you with your ability to





































A selection of relevant questions from the PROM for patient B. In MLHFQ 0 corresponds to ‘no’, 1 ‘very little’ and 5 ‘very much’.
In WHOQOL 1 corresponds to ‘very little’, 2 ‘poor’, 3 ‘neither poor nor good’, 4 ‘good’ and 5 ‘very good’. The patient self reports a
decrease in many aspects of well-being.
Did your heart valve disease prevent you from living as you wanted in the last 4 weeks by Pre-op Follow-up
... making you sit or lie down to rest during the day (MLHFQ) 1 2
... making your walking about or climbing stairs difficult (MLHFQ) 2 0
... making your working around the house or yard difficult (MLHFQ) 2 1
... making your going places away from home difficult (MLHFQ) 2 3
... making your sleeping well at night difficult (MLHFQ) 2 4
How well are you able to get around? (WHOQOL) 3 4
How satisfied are you with your ability to perform daily living activities? (WHOQOL) 4 4
How satisfied are you with your sleep? (WHOQOL) 3 2
Estimated hours per week you walk (SEQ) <1 1+
Once you go to bed do you fall asleep quickly? (SEQ) Most days Sometimes
Do you wake up fairly fully during the night? (SEQ) Rarely Most days
Do you get up during the night? (SEQ) Rarely Most days
Do you feel well-rested after sleep? (SEQ) Most days Never
6MWT distance (m) (6MWT) 268 330perform daily living activities?’, and ‘How satisfied are you with
your sleep?’. The former two questions may help validate activity
levels, while the latter the quality of sleep. The answers to these
questions are on a scale of 1 to 5, with 1 being ‘very dissatisfied’,
3 ‘neither dissatisfied or satisfied’ and 5 ‘very satisfied’.
The MLHFQ asks the patient to evaluate the impact their heart
alve disease has had on living as they wanted in the previous
our weeks. Questions are answered on a scale of 0 to 5 with
representing ‘No’, 1 ‘Very little’ and 5 ‘Very much’. Relevant
uestions in the MLHFQ include: has living with the heart valve
ondition prevented you from living as you wanted in the past
our weeks by (a) ‘making you sit or lie down to rest during the
ay’, (b) ‘making your walking about or climbing stairs difficult’,
c) ‘making your working around the house or yard difficult’, (d)
making your going places away from home difficult’, (e) ‘making
our sleeping well at night difficult’.
The 6 Minute Walk Test (6MWT) is a clinically validated tool
o assess exercise capacity and activity. The use of the 6MWT
as been studied in aortic stenotic patients [51,52], i.e., those
ecruited as part of this study. This test will gather information,
rom a single point in time, of the patients ability to walk for
prolonged period of time. Specifically, it records how many
eters they are able to walk and any issues that arose during it,
uch as if they had to stop. This makes it a suitable comparison
or the activity health indicators of Vesta.
.3.2. SPHERE EurValve questionnaire
The custom SPHERE EurValve Questionnaire (SEQ) is com-
osed of a number of questions that attempt to capture infor-
ation on the self-reported daily life on the patient undergoing
he monitoring. It contains questions specifically tailored to help
valuate the platform performance. A number of these questions
re selected to help evaluate the proposed platform.
In order to validate the activity recognition performance, the
esponses to questions such as how many estimated hours per
eek do they walk, garden, and exercise, are used. The possible
esponses to this question are either ‘None’, ‘Less than 1 hour’ or
1 or more hours’.
In order to validate the sleep analysis, the responses to the
uestion which asks the patient to report the typical times they
ake and go to sleep each day, is used. Further, the patient was
sked to report if, and if so, how often they wake and get up
uring the night. The responses to these questions are either
Never or Rarely’, ‘Sometimes’, or ‘Most days or Every day’.
.4. Case studies
In order to demonstrate the platform, and evaluate both use-
ulness and relevance of the results, two case studies are provided
n patients who have completed all three stages of the study.4.4.1. Cohort analysis
Before commencing the detailed case studies of two patients,
an analysis of 20 of the patients from the cohort will be carried
out. The analysis of these patients over each stage of the inter-
vention will measure the patient degree of change for measured
health indicators, in the post-operation and follow-up stages, rel-
ative to the health indicator values in pre-operation stage. Thus,
it provides a means of comparison for each case study patient,
each of which demonstrates a specific interesting outcome, to a
larger sample population.
Fig. 3 plots each of the six health indicators of interest. If the
pre-operation health of the patient is considered as the base-
line, these plots measure how much the patient has changed in
the measured indicators since their pre-operation level. In the
first column within each plot, for the first four indicators (room
transfers, duration outside, walking, sleep quality), the regression
line begins in the negative area of the plot. That is, there was a
negative change for each of these indicators in the post-operation
stage. Further, from the placement of the points, the majority of
patients fall below the 0 threshold, thereby exhibiting a decrease
in this health indicator value, ranging from 65% of patients (room
transfers) to 80% of patients (walking and duration outside).
This is to be expected, as soon after the operation, the patients
are expected to rest, and thus the amount of room transitions,
walking, and time spent outside should decrease. The drop in
sleep quality may be indicative of discomfort or pain, or increased
sleep duration beyond typical levels (7–9 h). In fact, the main
sleep time and total daily sleep time health indicators show 75%
and 90% of patients have increased values for these indicators in
the post-operation stage relative to the pre-operation stage. This
is also unsurprising, as again, patients are expected to rest more
after their operation.
The second column within each plot shows the patients
follow-up stage change in health indicators relative to the pre-
operation levels. In contrast to before, the first four plotted
indicators (room transfers, duration outside, walking, sleep qual-
ity), tend to increase in the follow-up stage, relative to the
pre-operation stage. The slope of the linear regression line is
positive for each, indicating patients are improving from post-
operation levels, with varying levels of steepness across each of
these four health indicators. For duration spent walking 85% of
patients had a positive slope (with 70% having a higher value than
pre-operation), for room transfers 80% of patients had a positive
slope (with 50% having a higher value than pre-operation), for
duration outside 80% of patients had a positive slope (with 55%
having a higher value than pre-operation), while for sleep quality
60% of patients had a positive slope (with 60% having a higher
value than pre-operation).


























iFig. 3. A comparison of four health indicators across 20 patients from the study, with each patient represented as a uniquely coloured point. Within each of the
six health indicator plots the x-axis consists of two columns, each representing the subsequent intervention stage relative to the pre-operation stage. The leftmost
column shows the change in the health indicator from pre-operation to post-operation. The rightmost column within each chart shows the change in the health
indicators in the follow-up stage to pre-operation. A point at 0 indicates there was no change for that patient, for that health indicator and study stage, relative to
their pre-operation value. If the point is positive then it indicates an increase in the value of that health indicator at that study stage, relative to the pre-operation
value, and vice versa if it is negative. A linear regression line is fit to demonstrate the patient recovery trajectory.Fig. 4. Sleep quality decreases in the post-operation stage, before recovering in the follow-up stage. Further, the duration of sleep increases post-operation, before
lso recovering in the follow-up, while the average sleep episodes remain similar.The daily main sleep length, and total sleep length, both have
negative slope indicating that for both indicators patients are
pending less time sleeping in the follow-up stage, compared to
re-operation levels. 24% of patients measured a positive slope
or their main sleep length (with 38% having a higher value than
re-operation), while only 19% of patients had a positive slope
or their total sleep time (with 42% having a higher value than
re-operation). If considered independently, the meaning of neg-
tive trend is unclear. However, this length should be considered
ointly with the sleep quality health indicator, which incorporates
leep length. As sleep quality increases over pre-operation levels,
he duration of sleep for the patients decreasing may mean that
atients were sleeping beyond the typical 7 to 9 h range in the
re-operation stage, but in the follow-up stage have dropped
loser to this range.
.4.2. Patient A
A small number of patients were selected randomly, and from
ithin this set, two patients who had different experiences were
elected. The first patient of the case study is patient A. They
re a 74 year old male undergoing mitral valve repair (MVR), a
ricuspid valve repair (TVR) and a coronary artery bypass graft
CABG), and they subjectively reported an improvement in symp-
oms following the operation. To gain confidence in the machine
earning models used to estimate health indicators, an evaluation
f the models on the training data is performed. In terms of
ocalization, the quality of the calibrations for indoor localization
s determined using the method described in Section 4.2.2. TheF1 micro score was evaluated to be 0.99 for the calibrations
carried out by patient A. The quality of the activity calibration was
also evaluated using the method described in Section 4.2.1 and
the F1 score to be 0.69. To ameliorate performance, the activity
calibrations of the two case study patients were removed, as they
were found to be causing a decrease in performance. When using
only the SPHERE challenge activity labels, the F1 score was 0.73.
The decrease in performance from the patient activity labels may
be explained by the unsupervised nature of the data labelling,
e.g., when calibrating the bedroom gateway, it is not known
apriori how far the bed is from the gateway, and thus the time
spent walking to the gateway would be mislabelled as lying. This
is in contrast to the SPHERE challenge dataset which was labelled
by multiple annotators observing recorded footage. Using the
models and methods described in Section 4.1, activity recognition
and indoor localization is performed on the data collected for
patient A.
To begin the case study an evaluation of the sleep analysis
component of Vesta is performed. In Fig. 4 three main health
indicators of interest are plotted from the previously described
method in Section 4.1.3. The sleep quality drops in the post-
operation stage, but recovers in the follow-up period. Their total
time spent sleeping each day increases by around four hours
in the post-operation period, and the number of sleep episodes
decreases only slightly, which recall, is any distinct period of
sleeping (e.g., naps). In the follow-up period the total daily sleep
time falls to around 8 h from around 10 h pre-operation, and 14 h
post-operation. Thus, for this patient from a sleep quality point














eFig. 5. Example of 2 days in the life of patient A in each stage of their care. Notable trends include the consistency of the time at which the patient goes to bed
each night, and leaves the bedroom in the morning. Interruptions to sleep in the night, by leaving the bedroom, can be seen, particularly post-operation. Further,
clear in the examples, there is more time spent outside the home in the follow-up period, indicative of increased mobility and confidence to leave the home. (For
interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)Fig. 6. Fig. 6(a) shows a decrease in room transfers post-operation, before increasing in the follow-up phase. In Fig. 6(b) the time spent outside of the home is
shown, and a significant increase in time spent outside in the follow-up period is found. When all health indicators, including Fig. 6(c) are considered holistically,
it can be inferred that the patient has an increased mobility by the follow-up stage, decreasing in the post-operation stage.of view, it appears that the intervention went well. The patient
experienced an increase in time spent sleeping and decrease in
sleep quality soon after surgery, before recovering in the follow-
up period, with a higher sleep quality than the pre-operation
level.
The output of Vesta is validated with the PROMs relating to
leep in Table 3. With regard to sleep quality, the patient self re-
orts in both pre-operation and follow-up stages that they rarely
ake up fairly fully during the night, and they sometimes get up
uring the night. As for feeling rested after sleep, they reported
sometimes’ pre-operation, and ‘most days’ in the follow-up. This
s a positive improvement in their self-reported quality of sleep.
Knowledge of which rooms the patient spends time in con-
ributes to building a narrative of the daily behaviour of a patient,
roviding clinicians with more insight into the well-being of the
atient. For example, if the patient is sleeping in their living-room
t may indicate that the patient is experiencing difficulty climbing
tairs. An example of a more detailed visualization of the daily
ehaviour of the patient can be seen in Fig. 5. They plot the indoor
ocation of the patient from midnight to midnight each day, with
ach bar representing a different room in the patients home.At the pre-operation stage, on each of the included example
days, there exists common behavioural patterns. The patient is in
the bedroom from around 1 A.M. and 2 A.M. until 10.30 A.M. or
11 A.M. (first third of each chart). They leave their house each
day (red blocks), spending the evening in the living room (blue)
or custom room (green), which we know to the ‘sun room’ or
‘study’ from the floor plans before going to the bedroom in the
early morning. In the post-operation stage there is a continuation
of routine behaviour. In both days shown there are periods where
the patient leaves the bedroom during the night, and on two
occasions at approximately the same time (5 am). Finally, in
the follow-up period there is a continuation of the behaviour
seen in the pre-operation and post-operation stages, but with
less frequent movement to other rooms during the night. In
comparison to before, the patient is now spending considerably
more time outside their home each day. This is reflected in the
PROM question in Table 3 in which the patient reports that their
condition has not prevented them from leaving the home in
the follow-up period, whereas it has some effect pre-operation.
The patients report in the SEQ forms that their normal sleeping

































mFig. 7. These plots (with 95% confidence intervals) reveal trends such as the consistent inactivity between 3 A.M. and 9 A.M. pre-operation, but 2 A.M. and 7 A.M.
in the post-operation and follow-up stage. This aligns with the time spent in bedroom, as well as the patient reported sleep times.Fig. 8. There is a consistent decrease in sleep quality after the patient has the operation, with the total daily sleep duration increasing post-operation, before falling
n the follow-up stage but with the number of sleep episodes remaining higher than pre-operation levels.imes are range from around 1.30 A.M. to 10 A.M., which can be
ssociated with time spent in bedroom above.
Another view of a patient’s mobility around the home is the
easurement of the number of transfers between rooms. By
easuring the room transfers before and after the operation, it is
ossible to observe any changes that may occur in the in-home
obility. Fig. 6(a) plots the room transfers for patient A over
he three stages. In the post-operation phase there is an average
aily decrease in room transfers, but with an increase over the
re-operation level in the follow-up stage. However, a single
ndividual measurement does not paint the complete picture.
ig. 6(b) reveals that the patient significantly increased their time
pent outside the home in the follow-up state. Together, this may
e indicative of increase in health and well-being.
Fig. 6(c) shows the predicted daily average time spent walking
uring the three phases of the intervention; pre-operation, post-
peration and the 12–16 week follow-up. This chart shows that
he patient has, as expected, a decreased duration of daily walking
he post-operation stage. However in the follow-up stage, the
mount of walking has increased over both previous stages. These
esults are also reflected in Fig. 7, which is an insight into the
verage hourly behaviour of the patient. Further, it also demon-
trates that the patient typically remains active until the early
ours of the morning (around 2 to 3 A.M.), agreeing with the
ocalization, sleep analysis, and patient reported sleep times.
The activity and mobility results are validated with the PROMs
n Table 3, in which the patient reported an increase in ability
o do ADL, e.g., their ability to get around, perform daily living
ctivities, and ability to leave the home. The 6MWT shows that
he patients increased the number of meters walked from 398 m
o 478 m in the clinical setting. While PROMs are subjective,
nd the 6MWT is a single measurement at a single point in
ime, they agree with the more detailed results of the analysis,
roviding validation to the much deeper insight of the pervasive
onitoring.The analysis shows that this is a patient who appears to have
recovered well from their heart valve intervention. Their key
behaviours remained consistent and improvements in sleep and
mobility (walking, room transfers and time spent outside) in the
follow-up period are apparent. As a further demonstration of the
proposed platforms capabilities, another case study is included on
another patient, but does not follow the example cohort trends
shown in Fig. 3 as closely as patient A, and subjectively reported
issues post-operation.
4.4.3. Patient B
The second case study is patient B who is a 87 year old female
undergoing a transcatheter aortic valve implantation (TAVI) pro-
cedure. Again an evaluation of the quality of the calibrations for
indoor localization are carried out using the method described in
Section 4.2.2, with the F1 score calculated to be 0.94. The same
activity recognition model as before is used.
The sleep analysis of the second case study, patient B, over
each stage is shown in Fig. 8. For patient B it is clear that
their sleep quality decreased in the post-operation stage, and
remains low in the follow-up stage. This is a clear downward
trend relative to pre-operation levels. While they maintained a
similar amount of total sleep per day in the pre-operation and
post-operation stage, the number of sleeping episodes increased,
i.e., their sleep became more fragmented after the operation. They
still maintain the fragmented sleep in the follow-up period, but
now with less time spent sleeping.
These results are validated with the PROMS in Table 4. For
example, in the pre-operation stage they report that they rarely
get up/wake up fairly fully during the night but in follow-up
period they report that most days they wake up fairly fully, and
get up, during the night. Similarly, during the pre-operation stage,
the patients are reportedly well-rested after sleeping on most
days, but never in the follow-up period. Clinical notes report that

















wFig. 9. Example of 2 days in the life of patient B at each stage of their intervention. At a high level changes in sleeping behaviour over the three stages are clear
as the patient no longer spends a single continuous block of time in the bedroom, rather it becomes fragmented in the post-operation period and follow-up stage.Fig. 10. Fig. 10(a) shows a fall in the number of room transfers in the post-operation stage, followed by an increase over the pre-operation levels in the follow-up
stage. There is a significant post-operation fall in the time spent outside the home in Fig. 10(b). The patient spends very little time outside the home at all stages,
and the large standard deviations highlight the wide variability in both the room transfers and time spent outside. There is a notable increase in the amount of
walking in the follow-up stage, shown in Fig. 10(c).patient B has restless leg syndrome, which is known to impair
sleep, and reportedly became worse after the operation.
Examples of this downward trend are also apparent in the
ocation charts in Fig. 9. In their pre-operation example days the
atient tends to spend considerable time in the bedroom between
A.M. and 8.30 A.M. In the post-operation stage their previously
onsistent time in the bedroom has become fragmented and
ore time is being spent in the living room, with fairly frequent
ovement to the kitchen. Finally in the follow-up period, again,
here is much fragmentation in which room the patient spends
he night in. This is a consistent trend. In the pre-operation stage
he patient spent the majority of the night in the bedroom, which
ecame more fragmented post-operation, and worse again in the
ollow-up. It is also clear throughout on many days that relatively
ittle time is spent outside the home.
Fig. 10 shows the activity levels of patient B over each stage
f the intervention. In the two weeks of monitoring soon after
he operation their amount of walking had decreased, indicating
ore rest was occurring, reinforced by more time spent inside the
ome. Moreover, clinical notes report that the patient required a
alking stick as an aid after the operation. Finally, the increasein walking and room transfers in the follow-up stage may be
explained by the routine physiotherapist recommendation of a
gradual increase of physical activity following surgery. By week
four patients are often told activity should include a 20 min walk
each day, and following their procedure, the patient reported
spending less time outside the home due to increased dizziness
and less confidence in mobility. This is demonstrated in Figs. 9
and 10(a)–10(c). Thus, this patient may have followed the advice
of the physiotherapists by exercising within their home, which
is consistent with the analysis. This is demonstrated by Fig. 10
which shows that there is an increase in room transfers and
walking at the follow-up stage, with relatively little time spent
outside. Fig. 11 reinforces this by showing an increase in both
room transfers and walking throughout the day.
While it is possible to compare the case study patients with
each other, or with the sample cohort analysis, e.g., trends in
room transfers, duration outside, walking etc., it should also be
kept in mind that these indicators are not independent. As the
room transfers increase, it is expected that the time spent walking
increases. Further, as these two indicators are only captured
at home, they also are dependent on the daily duration spent

















































oFig. 11. The average hourly number of room transfers (a) and time spent walking (b) over the three stages of monitoring. Spikes in room transfers often occur with
pikes in time spent walking, but not always. It is clear that the patient typically has lower levels of activity between 1 A.M. and 7 P.M. We can see that there are
igher levels of room transfers and walking in the follow-up stage across most of the day.utside the home. Evidence of the importance of this is when
omparing the room transfers of patient B with patient A. While
oth trends are similar over the stages, patient B did not increase
heir time spent outside the home in the follow-up stage, instead
t remained relatively little. So while the absolute number of room
ransfers was higher for patient B, they also spent on average four
ess hours per day outside their home. Thus, when comparing
atients, all health indicators must be judged in an holistic way.
inally, for patient B, and unlike patient A, in addition to the
ohort analysis in Fig. 3, the sleep quality of patient B did not
mprove in the follow-up stage, rather it remained low, as did the
verage time spent outside the home. These results indicate that
he patient may have experienced problems after the operation.
More generally, the provided analysis, covering various as-
ects of health and well-being, highlights the benefit of exam-
ning multiple health indicators and reinforces the importance of
he more holistic view that this system provides.
The PROMs in Table 4 reveal a mixed picture of the self-
eported recovery of the patient. The patient still finds that their
ondition requires them to rest during the day, and causes dif-
iculty working around the house, albeit self-reported as ‘very
ittle’. This can be compared with patient A who self-reported that
ith the same questions, their condition no longer had any effect.
owever, like patient A, Fig. 10(b) shows that the time spent
utside increases in the follow-up stage from post-operation.
owever, in the case of patient B, the time spent outside is similar
o pre-operation, and less than one hour per day on average in the
re-operation and follow-up stage. This is in contrast to patient A
hose time spent outside increased from around 2 h per day on
verage pre-operation to over four hours per day in the follow-up
tage. The patient self-reports in Table 4 that their condition had
very little’ (2) effect on their ability to go places away from the
ome pre-operation, and an increased effect (3) in the follow-up
eriod. Again, contrast this with patient A, who reported ‘very
ittle’ effect pre-operation and ‘no’ effect in the follow-up period.
Table 4 reports an increase in the amount of walking, and the
atient also reported that their ability to perform activities of
aily living remained ‘good’. In the 6MWT they walked 268 m
re-operation, with clinical notes reporting that they had to stop
or 30 s due to angina. In the follow-up stage 6MWT they walked
30 m, which is an increase of 62 m. While this is an improve-
ent, clinical notes note that the patient suffered from dizziness.
s discussed, this increase in the capacity for walking is reflected
n the results from Vesta. As discussed previously, there is a clear
ecline in sleep quality reported by Vesta, as well as the patient
n Table 4.
Finally, some examples of the power of Vesta in being able
o quantify health indicators can be found in the previous anal-
sis. Health indicators such as the time spent outside, for which
oth patients reported their condition had ‘very little’ effect pre-
peration on their ability to go away from the home, but yet thetime spent outside for each patient differed by an hour each day
on average. When self-reporting measures regarding their sleep
patient B reported it was ‘neither poor nor good’ and then ‘poor’
quality sleep satisfaction in the follow-up period. The quantified
sleep quality index within Vesta reflected this, with a 20% drop
in the sleep quality between in the two periods. Interestingly,
patient A reported that their sleep satisfaction was ‘good’ in the
pre-operation stage, with a lower average sleep quality index
(0.64) than patient B (0.67) who had reported lower sleep satis-
faction. This may be indicative of the subjective nature of PROMs.
Nonetheless, the trends of the individual patients over their in-
tervention tend to reflect the trend of their own self-reported
measures, validating the proposed system.
5. Conclusion
This paper presented a novel digital health platform, Vesta, an
end-to-end lower-cost platform for interventions which monitor
the activity, health and well-being of patients in their home en-
vironment. The platform’s smart home in a box was discussed in
detail, including how it was designed to be lower cost than similar
systems and easy to use, yet ubiquitous in its data collection.
The collection of accelerometer data from a wrist-worn wearable,
along with RSSI values at four points throughout the home, was
outlined, and how this collects a large amount of valuable in-
home data. The analytics system was introduced, and how it uses
data science and machine learning for activity recognition, indoor
localization and sleep analysis to produce health and well-being
health indicators. These are then visualized facilitating the deriva-
tion of useful insights from the large amount of raw sensor data
collected by the smart home in a box. Finally the effectiveness
of Vesta for digital health studies was evaluated on a sample
cohort of 20 patients, as well as two detailed case studies, of heart
valve intervention patients. Over three stages, one before and two
after the operation, it was demonstrated how the platform could
produce both granular and high level insights into the activity
and behaviour of the patients within their home. Using a number
of relevant measures, including activity levels and sleep quality,
the results were validated with standardized clinical PROMs and
a customized survey. The potential of the proposed platform,
to augment current clinical measures with quantitative health
measurements from pervasive home monitoring, in digital health
studies is demonstrated.
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